Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants

For parents watching a baby's skin turn dry, red, and irritated in the first months of life, the worry is rarely only about the rash itself — it's whether this is the opening act of a food allergy diagnosis still to come. A new study in the journal Allergy suggests the skin itself may be dropping hints of that future, by tracking the bacteria and fungi living on infants' cheeks and inner elbows starting at just 2 to 3 months of age. Rather than one microbial signature for eczema and one for health, researchers found the skin microbiome splits along a finer line: it looks different depending on whether an infant's eczema travels alone or arrives together with food allergy or food sensitization.

Key takeaways:

• In a study of 429 infants, distinct skin bacterial and fungal signatures distinguished eczema alone from eczema paired with food allergy or food sensitization, both before and after diagnosis.
• Before any diagnosis, at just 2-3 months old, skin already showed early enrichment of certain bacteria — including Staphylococcus aureus — specifically in infants who went on to develop eczema together with food allergy, not in those who developed eczema alone.
• The real-world implication: skin bacteria could eventually help flag which eczema infants carry a higher risk of also developing food allergy, offering a path toward earlier risk stratification.
• The headline caveat: this is an observational, single-country cohort finding a correlation, not a validated test or treatment — no clinical tool exists yet, and mothers and infants shared bacterial strains, hinting that household exposure shapes the pattern too.

Distinct Skin Microbiome Signatures Separate Eczema Alone From Eczema With Food Allergy

Skin swabs from 429 infants show that atopic dermatitis (AD, the clinical term for eczema) is not one microbial story: the bacteria and fungi on affected skin differed depending on which allergic condition rode along with it. Using deep shotgun metagenomic sequencing (a DNA method that reads nearly all genetic material in a sample rather than a single marker gene, enabling species-, strain-, and gene-level detail), researchers at the US National Institutes of Health and Melbourne's Murdoch Children's Research Institute analyzed over 1,000 skin swabs from the cheek and inner elbow crease (antecubital fossa) at 2-3 months and again at 12 months. At 12 months, infants with eczema alone had skin enriched with Staphylococcus epidermidis (a common, usually harmless skin bacterium), while infants with eczema plus food allergy instead showed less Staphylococcus hominis and Lactococcus, alongside more Dermacoccus nishinomiyaensis and the yeast Malassezia slooffiae. A third pattern turned up in babies with eczema and food sensitization (a positive allergy test without a confirmed clinical reaction): reduced Prevotella melaninogenica and Veillonella, bacteria more often discussed in gut research. Notably, one species, Lactococcus cremoris, was the only microbe whose abundance tracked inversely with eczema severity, measured using SCORAD (a standardized clinical eczema-severity index) — the less of it present, the worse the eczema.

Why This Matters for Families Managing Infant Eczema and Food Allergy

Eczema affects up to 20% of children, mostly starting in the first year of life, and it frequently sits at the front of what allergists call the "atopic march" — the tendency for infant eczema to be followed by food allergy, and later by hay fever and asthma. Parents of a baby with new eczema often want to know one thing: will this progress into a food allergy? This study can't answer that for an individual child, but it shows the co-occurrence isn't random noise — it corresponds to a measurably different skin ecosystem. In this cohort, 73 of 95 infants with food allergy, and 31 of 55 with food sensitization, also had eczema, echoing the broader clinical pattern in which the two conditions travel together, a link earlier reviewed in the same journal. Distinguishing these two groups using something as simple as a skin swab, rather than a blood draw or food challenge, is an early step toward treating skin bacteria as markers of which branch of the atopic march a child is on, not just bystanders.

Inside the 429-Infant VITALITY Cohort Study Design

This analysis was nested inside VITALITY, a randomized, double-blind, placebo-controlled trial run in metropolitan Melbourne, Australia that was originally designed to test whether oral vitamin D supplementation in infancy reduces food allergy risk; the microbiome work rode on that trial's infrastructure rather than testing vitamin D itself. Researchers recruited healthy, term infants at 6 to 12 weeks old and followed them to 12 months, when trained clinicians diagnosed eczema using SCORAD and diagnosed food allergy using oral food challenges (a supervised feeding test considered the clinical gold standard) plus skin-prick testing — a notably rigorous way to define allergy status compared with parent-reported symptoms alone. Of the 429 infants, 171 had eczema alone, 73 had eczema with food allergy, 31 had eczema with food sensitization, and 108 were healthy controls. The team also sequenced 70 skin samples from mothers and applied strain-tracking software to compare individual bacterial strains, not just species, across family members, building on earlier NIH strain-level work on Staphylococcus diversity in childhood eczema. That scale and resolution set this study apart from earlier work using lower-resolution sequencing.

What Skin Microbiome Clues Mean for Parents Right Now

For a parent today, the honest answer is: not much yet, in practical terms. This is an observational cohort study — it shows that microbial patterns and eczema-plus-allergy outcomes travel together in time, not that the bacteria cause the allergy or that altering them would prevent it. Nothing here validates a probiotic, skin cream, or supplement as a way to shift a baby's future risk; the researchers tested no intervention at all. What's worth raising with a pediatrician is context, not action: whether food allergy testing is warranted for a baby with early, persistent eczema remains a decision based on established clinical guidelines, not on skin-swab microbiology. The genuine future value the authors point to is earlier risk stratification — flagging, before symptoms or a food challenge, which eczema infants might benefit from closer allergy monitoring. That kind of test does not exist yet.

What This Study Can't Yet Answer About Eczema Risk

Several limitations temper how far these findings travel. The cohort was drawn entirely from one country, Australia, and the authors say generalizability elsewhere needs testing directly. Most eczema cases here were mild (median SCORAD score of 7.9), so it's unclear whether the same patterns hold in severe eczema. The study could not account for prior antibiotic exposure, which independently reshapes skin bacteria, and because it was nested inside a still-blinded vitamin D trial, a vitamin D effect on the microbiome can't be fully excluded. Group sizes for food-allergy-only, food-sensitization-only, and the earliest 2-3 month timepoint were relatively small, which limits confidence in some negative findings — an absence of a detected difference in a small group doesn't prove no real difference exists.

Next Steps Toward an Early-Life Allergy Risk Signature

The researchers frame this as a first step toward early risk stratification, not a finished tool. Next, the specific signatures need replication in other populations, and it needs to be established whether the strain-level bacterial gene variants they found — including a mutation in a Staphylococcus aureus gene linked to milder eczema, and one in a Streptococcus thermophilus gene linked to worse eczema — actually contribute to disease, since these associations are, by the authors' own account, hypothesis-generating rather than proven. A second open question is transmission: infants and mothers frequently shared identical bacterial strains (in 8 of 9 families where both carried detectable S. aureus, it was the same strain), suggesting household contact shapes which microbes colonize a baby's skin. The authors call for future work to trace how and when that transmission happens; no timeline for a clinical test was given.

Common Questions

Does this mean my baby's eczema will turn into a food allergy? No. The study found different skin bacteria patterns in infants who had eczema alone versus eczema with food allergy, but it cannot predict any individual infant's future, and it did not test whether changing the skin microbiome changes allergy risk.

What is Staphylococcus aureus and why does it matter here? It's a common bacterium that, in this study, was already elevated on the skin of some infants before diagnosis — specifically in infants who went on to develop eczema together with food allergy, not eczema alone — making it one of the earliest microbial differences the researchers detected.

Can a skin swab test predict food allergy in babies right now? Not currently. This research points toward that possibility for the future, but the microbial patterns found here haven't been validated as a diagnostic tool, and no clinical test based on these findings exists yet.

Does a mother's own bacteria affect her baby's skin microbiome? The study found infants often carried identical bacterial strains to their mothers, suggesting household and family contact play a role in shaping an infant's skin microbiome, though the study wasn't designed to isolate any single source of that transmission.

References

1. Zeyang Shen, Jana K. Eckert, Richard Saffery, et al. (2026). Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease. Allergy. https://doi.org/10.1111/all.70449
2. Elizabeth Huiwen Tham, Minghao Chia, Carmen Riggioni, Niranjan Nagarajan, John E. A. Common, Heidi H. Kong (2024). The skin microbiome in pediatric atopic dermatitis and food allergy. Allergy. https://doi.org/10.1111/all.16044
3. Allyson L. Byrd, Clay Deming, Sara K. B. Cassidy, et al. (2017). Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aal4651